Cytori Therapeutics Inc Warrant
CYTXW
CYTXW was delisted on the 14th of December, 2018.
5 hedge funds and large institutions have $1.74M invested in Cytori Therapeutics Inc Warrant in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$674K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$302K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$593 |
| 4 |
KLI
Kelman-Lazarov Inc
Memphis,
Tennessee
|
+$134 |
| 5 |
MCM
Manchester Capital Management
Manchester,
Vermont
|
+$5 |
Top Sellers
CYTXW Hedge Fund Activity: Q2 2016 in Review
5 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q2 2016, worth a combined $1.74M.
Buyers outnumbered sellers: 5 funds opened new CYTXW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $674K.
- 5 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $1.74M of Cytori Therapeutics Inc Warrant stock for Q2 2016.
- 5 funds opened new Cytori Therapeutics Inc Warrant positions in Q2 2016 and 0 closed out, a net change of +5 holders.
- The largest Cytori Therapeutics Inc Warrant buyer in Q2 2016 was Sabby Management, an estimated $674K added.
Based on aggregated 13F filings for Q2 2016.